3rd Circ. To Decide If Reverse Payments Must Be Cash

Law360, New York (November 17, 2014, 4:19 PM EST) -- The Third Circuit on Wednesday will become the first court of appeals to take on a pay-for-delay case since the U.S. Supreme Court ruled the pharmaceutical patent settlements could face antitrust scrutiny, weighing the key question of whether generic-drug makers must receive cash for a deal to count as a reverse payment.

A three-judge panel is set to hear arguments over whether a New Jersey district court correctly concluded that the justices were only talking about cash settlements when they opened the door to antitrust challenges...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.